Pasar al contenido principal

DESCIFRANDO LOS MECANISMOS PATOLOGICOS Y TERAPEUTICOS EN LA DEFICIENCIA PRIMARIA EN COENZIMA Q

PID2021-126788OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE GRANADA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

4-Hydroxybenzoic acid rescues multisystemic disease and perinatal lethality in a mouse model of mitochondrial disease

  • Corral-Sarasa, Julia
  • Martínez Gálvez, Juan Manuel
  • González-García, Pilar
  • Wendling, Olivia
  • Jiménez-Sánchez, Laura
  • López-Herrador, Sergio
  • Quinzii, Catarina M.
  • Díaz-Casado, María Elena
  • López, Luis C.
© 2024 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/)., Coenzyme Q (CoQ) deficiency syndrome is conventionally treated with limited efficacy using exogenous CoQ10. Poor outcomes result from low absorption and bioavailability of CoQ10 and the clinical heterogenicity of the disease. Here, we demonstrate that supplementation with 4-hydroxybenzoic acid (4HB), the precursor of the benzoquinone ring in the CoQ biosynthetic pathway, completely rescues multisystemic disease and perinatal lethality in a mouse model of CoQ deficiency. 4HB stimulates endogenous CoQ biosynthesis in tissues of Coq2 mutant mice, normalizing mitochondrial function and rescuing cardiac insufficiency, edema, and neurodevelopmental delay. In contrast, exogenous CoQ10 supplementation falls short in fully restoring the phenotype. The treatment is translatable to human use, as proven by in vitro studies in skin fibroblasts from patients with pathogenic variants in COQ2. The therapeutic approach extends to other disorders characterized by deficiencies in the production of 4HB and early steps of CoQ biosynthesis and instances of secondary CoQ deficiency., This work was supported by the grants PID2021-126788OB-I00 from the MICIU/AEI/10.13039/501100011033, Spain, and the ERDF/EU; MDA-602322 from the Muscular Dystrophy Association; and PEER-0083-2020 from the Junta de Andalucía. J.C.-S. and L.J.-S. were supported by the Consejería de Salud, Junta de Andalucía, Spain. J.M.M.-G. was supported by the “Margarita Salas program” from the Ministerio de Universidades, Spain. P.G.-G. was supported by University of Granada. S.L.-H. was supported by the “FPU program” from the Ministerio de Universidades, Spain. C.M.Q. is supported by DOD grant W81XWH2010807 and NIH grants R21AG077243-01A1 and 1R01NS134902-01. The authors are also thankful for the support of the Unit of Excellence “UNETE” from the University of Granada (UCE-PP2017-05)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Early heart and skeletal muscle mitochondrial response to a moderate hypobaric hypoxia environment

  • Aragón-Vela, Jerónimo
  • Casuso, Rafael A.
  • Aparisi, Ana Sagrera
  • Plaza-Díaz, Julio
  • Rueda-Robles, Ascensión
  • Hidalgo-Gutiérrez, Agustín
  • López, Luis Carlos
  • Rodríguez-Carrillo, Andrea
  • Enriquez, José Antonio
  • Cogliati, Sara
  • Huertas, Jesús R.
Abstract: In eukaryotic cells, aerobic energy is produced by mitochondria through oxygen uptake. However, little is known about the early mitochondrial responses to moderate hypobaric hypoxia (MHH) in highly metabolic active tissues. Here, we describe the mitochondrial responses to acute MHH in the heart and skeletal muscle. Rats were randomly allocated into a normoxia control group (n = 10) and a hypoxia group (n = 30), divided into three groups (0, 6, and 24 h post-MHH). The normoxia situation was recapitulated at the University of Granada, at 662 m above sea level. The MHH situation was performed at the High-Performance Altitude Training Centre of Sierra Nevada located in Granada at 2320 m above sea level. We found a significant increase in mitochondrial supercomplex assembly in the heart as soon as the animals reached 2320 m above sea level and their levels are maintained 24 h post-exposure, but not in skeletal muscle. Furthermore, in skeletal muscle, at 0 and 6 h, there was increased dynamin-related protein 1 (Drp1) expression and a significant reduction in Mitofusin 2. In conclusion, mitochondria from the muscle and heart respond differently to MHH: mitochondrial supercomplexes increase in the heart, whereas, in skeletal muscle, the mitochondrial pro-fission response is trigged. Considering that skeletal muscle was not actively involved in the ascent when the heart was beating faster to compensate for the hypobaric, hypoxic conditions, we speculate that the different responses to MHH are a result of the different energetic requirements of the tissues upon MHH. (Figure presented.). Key points: The heart and the skeletal muscle showed different mitochondrial responses to moderate hypobaric hypoxia. Moderate hypobaric hypoxia increases the assembly of the electron transport chain complexes into supercomplexes in the heart. Skeletal muscle shows an early mitochondrial pro-fission response following exposure to moderate hypobaric hypoxia., Julio Plaza-Diaz is supported by a grant awarded to postdoctoral researchers at foreign universities and research centres from the ‘Fundación Ramón Areces’, Madrid, Spain. The present study was supported by grant PID2022-140453OB-I00 financedby MICIU/AEI/10.13039/501100011033 and the FEDER, UE.Sara Cogliati is a recipient of a ‘Ramón y Cajal fellowship 23013-2017’ founded by MCIN/AEI/10.13039/501100011033and ‘El FSE invierte en tu futuro’. Research in Sara Cogliati’s labis supported by the Grant PID2020-114054RA-I00 1001100482 founded by MCIN/AEI/10.13039/501100011033. Luis C.López is supported by grant PID2021-126788OB-I00 fromthe MICIU/AEI/10.13039/501100011033, Spain, and the ERDF/EU. This research was supported by a Marie S. Curie Global Fellowships within the European Union researchand innovation framework programme Horizon Europe (2021-2027) (AHG), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Sexual dimorphism on the acute effect of exercise in the morning vs. evening: A randomized crossover study

  • Sevilla Lorente, Raquel
  • Mármol Pérez, Andrés
  • González-García, Pilar
  • Rodríguez Miranda, María de Las Nieves
  • Riquelme Gallego, Blanca
  • Aragón Vela, Jerónimo
  • Martínez Gálvez, Juan Manuel
  • Molina García, Pablo
  • Alcántara, Juan Manuel A.
  • Garcia Consuegra, José
  • Cogliati, Sara
  • Salmerón, Luis Miguel
  • Huertas, Jesús R.
  • López, Luis C.
  • Ruiz, Jonatan R.
  • Amaro Gahete, Francisco José
[Background] Mammalian cells possess molecular clocks, the adequate functioning of which is decisive for metabolic health. Exercise is known to modulate these clocks, potentially having distinct effects on metabolism depending on the time of day. This study aimed to investigate the impact of morning vs. evening moderate-intensity aerobic exercise on glucose regulation and energy metabolism in healthy men and women. It also aimed to elucidate molecular mechanisms within skeletal muscle., [Methods] Using a randomized crossover design, healthy men (n = 18) and women (n = 17) performed a 60-min bout of moderate-intensity aerobic exercise in the morning and evening. Glucose regulation was continuously monitored starting 24 h prior to the exercise day and continuing until 48 h post-exercise for each experimental condition. Energy expenditure and substrate oxidation were measured by indirect calorimetry during exercise and at rest before and after exercise for 30 min. Skeletal muscle biopsies were collected immediately before and after exercise to assess mitochondrial function, transcriptome, and mitochondrial proteome., [Results] Results indicated similar systemic glucose, energy expenditure, and substrate oxidation during and after exercise in both sexes. Notably, transcriptional analysis, mitochondrial function, and mitochondrial proteomics revealed marked sexual dimorphism and time of day variations., [Conclusion] The sexual dimorphism and time of day variations observed in the skeletal muscle in response to exercise may translate into observable systemic effects with higher exercise-intensity or chronic exercise interventions. This study provides a foundational molecular framework for precise exercise prescription in the clinical setting., This study was funded by the Spanish Ministry of Culture and Sport, Consejo Superior de Deportes, Plan de Recuperación, Transformación y Resiliencia, Unión Europea, Next Generation EU; Ayudas Europeas a Proyectos de Investigación Aplicada a la Actividad Física Beneficiosa para la Salud y la Medicina Deportiva (EXP_77437); by the Spanish Ministry of Science and Innovation (PID2022-141506OB-I00) and the European Regional Development Funds (ERDF); by the University of Granada Plan Propio de Investigación-Excellence actions: Unit of Excellence on Exercise Nutrition and Health (UCEENS); RSL and AMP are supported by the Spanish Ministry of Education, Culture and Sport (FPU19/03745 and FPU20/05530, respectively); JMAA is supported by the Juan de la Cierva-Formación Grant FJC2020-044453-I funded by Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033 and European Union NextGeneration, Plan de Recuperación, Transformación y Resilencia (EU/PRTR); SC is a recipient of a “Ramón y Cajal fellowship 2013–2017” funded by MCIN/AEI /10.13039/501100011033 and “El Fondo Social Europeo invierte en tu futuro”. Research in Sara Cogliati lab is partially supported by the Grant PID2020-114054RA-I00 1001100482, funded by MCIN/AEI/10.13039/501100011033. Research in LCL lab is supported by a grant from the MCIN/AEI/10.13039/501100011033, Spain, and the ERDF (PID2021-126788OB-I00)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

N-Acetylglucosamine Selectively Attenuates Neuroinflammation in a Mouse Model of Mitochondrial Dysfunction

  • Jiménez-Sánchez, Laura
  • Ruiz-López, Paula
  • González-García, Pilar
  • Purhonen, Janne
  • Martínez Gálvez, Juan Manuel
  • López-Herrador, Sergio
  • Corral-Sarasa, Julia
  • Díaz-Casado, María Elena
  • Venegas, Carmen
  • Santos-Pérez, Isaac
  • Olivieri, Enrica
  • Rojas, Adriana L.
  • López, Luis Carlos
[Aim] Mitochondrial dysfunction plays a central role in multiple neurodegenerative diseases, yet the temporal sequence of cellular events underlying neurodegeneration remains poorly defined. This study aimed to characterize the progression of neurodegeneration in a mouse model of fatal mitochondrial encephalopathy and to evaluate the therapeutic potential of oral N-acetylglucosamine supplementation., [Methods] A mouse model of primary coenzyme Q deficiency was used to examine neurodegeneration at presymptomatic, symptomatic and terminal stages. Neuronal integrity, glial activation, myelination and inflammatory responses were assessed using histological, molecular and ultrastructural approaches, together with behavioral analysis of motor coordination. N acetylglucosamine was administered orally from 1 month of age, and its effects on neuroinflammation, myelin integrity and motor performance were evaluated., [Results] Astrocyte activation and neuronal loss were detected before the onset of clinical symptoms, whereas proinflammatory microglia appeared at later disease stages. Early myelin abnormalities were accompanied by an initial increase in oligodendrocyte precursor cells, suggesting a compensatory response to early myelin stress. Oral N-acetylglucosamine supplementation reduced glial activation and neuroinflammatory markers, likely through modulation of inflammatory signaling pathways. Although treatment did not fully reverse structural damage or restore myelin protein expression, it led to a significant improvement in motor coordination., [Conclusion] These findings define a temporal sequence of early glial activation, neuronal loss, and myelin alterations in mitochondrial encephalopathy. Targeting glial responses and neuroinflammation at early disease stages may mitigate neurodegenerative progression and improve functional outcomes, highlighting a physiologically relevant therapeutic window for mitochondrial disorders., [Practitioner Points], Early glial and neuronal loss precede microglial activation in mitochondrial encephalopathy., Myelin damage is an early phenomenon in mitochondrial pathology., GlcNAc reduces inflammation by inhibiting NF-κB and NLRP3 pathways., The authors are also thankful for the support of the Unit of Excellence “UNETE” from the University of Granada (UCEPP2017-05). This work was supported by the grants PID2021-126788OB-I00 from the MICIU/AEI, Spain and the ERDF/EU; and PI-0203-2024 from la Consejería de Salud y Consumo de la Junta de Andalucía. S.L.-H. was supported by the “FPU program” from the Ministerio de Universidades, Spain. The authors are also thankful for the support of the Unit of Excellence “UNETE” from the University of Granada (UCEPP2017-05). J.C.-S. was supported by the Conserjería de Salud, Junta de Andalucía, Spain. S.L.-H. was supported by the “FPU program” from the Ministerio de Universidades, Spain. L.J.-S. was supported by Conserjería de Salud, Junta de Andalucía, Spain. This work was funded by the Sigrid Jusélius Foundation (support to J.P.)., Peer reviewed